Pfizer COVID Vaccine Lawsuit – Latest Updates
The “pfizer covid vaccine lawsuit” in the U.S. is limited by federal immunity rules, but some states are pursuing
The “pfizer covid vaccine lawsuit” in the U.S. is limited by federal immunity rules, but some states are pursuing claims over misleading advertising and patent disputes are also active.
Immunity & Compensation Pathway
Under U.S. law, COVID-19 vaccines are treated as “covered countermeasures,” which means ordinary lawsuits against Pfizer for vaccine-related harm are largely blocked.
Claimants must use the Countermeasures Injury Compensation Program (CICP) rather than sue in court, unless they can prove that Pfizer acted with willful misconduct.
The CICP provides narrow compensation for serious injuries or death, but has strict evidentiary requirements and does not allow broad appeals.
State Lawsuits Over Misleading Claims
Texas Lawsuit
Texas sued Pfizer claiming it misrepresented how effective and safe its COVID vaccine was, and that it worked with social media platforms to suppress criticism.
A federal court dismissed that case due to the federal immunity shield. Texas then filed an appeal to keep the case alive.
Kansas Lawsuit
Kansas filed a lawsuit accusing Pfizer of misleading the public by hiding risks, such as pregnancy complications and heart inflammation, and overstating transmission prevention.
A federal judge recently agreed to send (remand) the Kansas case back to state court, meaning Kansas can proceed under its state consumer protection laws.
Patent & Technology Disputes
Some litigation isn’t about vaccine injuries but about patent rights and technology:
- Pfizer and BioNTech have been challenged by other firms claiming patent infringement over mRNA or lipid nanoparticle technology.
- In one case, another company dropped its patent suit against Pfizer for now, suggesting that infringement was not established.
- Pfizer has also successfully invalidated some patents asserted by competitors.
These disputes affect licensing, royalties, and control over vaccine technology.
Challenges for Plaintiffs
- High proof standard: To win compensation under CICP, claimants need very strong medical and scientific evidence linking injury to the vaccine.
- Limited damages: CICP does not offer large awards for pain and suffering or punitive damages as in regular lawsuits.
- Strict time limits: Claims must be filed within a set period after the injury or vaccination.
- Immunity barrier: Without proving willful misconduct, most direct tort claims are barred.
Recent Updates
- Texas’s appeal continues after dismissal.
- Kansas’s false advertisement claims now will be heard in state court.
- Some patent cases have been dropped or resolved; Pfizer has also prevailed in invalidating certain patent claims.
- The total number of COVID-vaccine injury claims filed with the CICP is in the thousands, but only a very small percentage are awarded compensation.
